Back to search
FDAFDA · Food and drugs·Recall number Z-0258-2025

17-OH Progesterone ELISA 96 well kit- An enzyme immunoassay for the quantitative in vitro diagnostic measurement of 17-OH Progesterone (17-OHP) in serum or plasma Model/Catalog Number: EIA-1292

Published November 6, 2024 · Recall initiated: September 13, 2024

Summary

FDA records medical device Class III recall Z-0258-2025, published November 6, 2024 and initiated September 13, 2024. Recalling firm: DRG International, Inc.; Status: Ongoing; Reported quantity: 504 units; Lot: Lot Code: 04048474012927 (DRG Instruments GmbH) lots: 22K024 and 22K034. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance range information on the High and Low Control Component labels. Due to the defect, the device failed to provide results, which may result in a delay in obtaining test results and a remote chance of an adverse health risk.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
DRG International, Inc.
Distributor
AZ, CA, NH Foreign: Austria Belgium Georgia Germany Greece India Irak Italy Netherlands Poland Romania Russia Singapore Spain Tunesia Vietnam
Lot
Lot Code: 04048474012927 (DRG Instruments GmbH) lots: 22K024 and 22K034
Risk classification
Class III
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was 17-OH Progesterone ELISA 96 well kit- An enzyme immunoassay for the quantitative in vitro diagnostic measurement of 17-OH Progesterone (17-OHP) in serum or plasma Model/Catalog Number: EIA-1292 recalled?

Yes. FDA published recall Z-0258-2025 on November 6, 2024. Reported hazard: The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance range information on the High and Low Control Component labels. Due to the defect, the device failed to provide results, which may result in a delay in obtaining test results and a remote chance of an adverse health risk.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail